Your browser doesn't support javascript.
loading
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.
Sainz de la Maza, Susana; Maurino, Jorge; Castillo-Triviño, Tamara; Borges, Mónica; Sebastián Torres, Berta; Sotoca, Javier; Alonso Torres, Ana María; Caminero, Ana B; Borrega, Laura; Sánchez-Menoyo, José L; Barrero-Hernández, Francisco J; Calles, Carmen; Brieva, Luis; Blasco, María Rosario; Dotor García-Soto, Julio; Rodríguez-Regal, Ana; Navarro-Cantó, Laura; Agüera-Morales, Eduardo; Garcés, Moisés; Carmona, Olga; Gabaldón-Torres, Laura; Forero, Lucía; Hervás, Mariona; Gómez-Ballesteros, Rocío.
Afiliación
  • Sainz de la Maza S; Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Maurino J; Medical Department, Roche Farma, Madrid, Spain.
  • Castillo-Triviño T; Department of Neurology, Hospital Universitario Donostia, San Sebastián, Spain.
  • Borges M; Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Sebastián Torres B; Department of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Sotoca J; Department of Neurology, Hospital Universitari Vall d´Hebrón, Barcelona, Spain.
  • Alonso Torres AM; Department of Neurology, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Caminero AB; Department of Neurology, Complejo Asistencial de Ávila, Ávila, Spain.
  • Borrega L; Department of Neurology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
  • Sánchez-Menoyo JL; Department of Neurology, Hospital de Galdakao-Usansolo, Galdakao, Spain.
  • Barrero-Hernández FJ; Department of Neurology, Hospital Universitario Clínico San Cecilio, Granada, Spain.
  • Calles C; Department of Neurology, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
  • Brieva L; Department of Neurology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Blasco MR; Department of Neurology, Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Dotor García-Soto J; Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Rodríguez-Regal A; Department of Neurology, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
  • Navarro-Cantó L; Department of Neurology, Hospital General Universitario de Elche, Elche, Spain.
  • Agüera-Morales E; Department of Neurology, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Garcés M; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Carmona O; Department of Neurology, Fundació Salut Empordà, Figueres, Spain.
  • Gabaldón-Torres L; Department of Neurology, Hospital Francesc de Borja, Gandía, Spain.
  • Forero L; Department of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain.
  • Hervás M; Department of Neurology, Consorci Corporació Sanitària Parc Taulí, Sabadell, Spain.
  • Gómez-Ballesteros R; Medical Department, Roche Farma, Madrid, Spain.
Patient Prefer Adherence ; 17: 1431-1439, 2023.
Article en En | MEDLINE | ID: mdl-37337517
ABSTRACT

Background:

Hopelessness is a risk factor for depression and suicide. There is little information on this phenomenon among patients with relapsing-remitting multiple sclerosis (RRMS), one of the most common causes of disability and loss of autonomy in young adults. The aim of this study was to assess state hopelessness and its associated factors in early-stage RRMS.

Methods:

A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0-5.5 were included. The State-Trait Hopelessness Scale (STHS) was used to measure patients´ hopelessness. A battery of patient-reported and clinician-rated measurements was used to assess clinical status. A multivariate logistic regression analysis was conducted to determine the association between patients' characteristics and state hopelessness.

Results:

A total of 189 patients were included. Mean age (standard deviation-SD) was 36.1 (9.4) years and 71.4% were female. Median disease duration (interquartile range-IQR) was 1.4 (0.7, 2.1) years. Symptom severity and disability were low with a median EDSS (IQR) score of 1.0 (0, 2.0). A proportion of 65.6% (n=124) of patients reported moderate-to-severe hopelessness. Hopelessness was associated with older age (p=0.035), depressive symptoms (p=<0.001), a threatening illness perception (p=0.001), and psychological and cognitive barriers to workplace performance (p=0.029) in the multivariate analysis after adjustment for confounders.

Conclusion:

Hopelessness was a common phenomenon in early-stage RRMS, even in a population with low physical disability. Identifying factors associated with hopelessness may be critical for implementing preventive strategies helping patients to adapt to the new situation and cope with the disease in the long term.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article